摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-Dimethyl-5-tert.butyl-pyrrol | 13138-18-6

中文名称
——
中文别名
——
英文名称
2,3-Dimethyl-5-tert.butyl-pyrrol
英文别名
5-tert-butyl-2,3-dimethyl-1H-pyrrole
2,3-Dimethyl-5-tert.butyl-pyrrol化学式
CAS
13138-18-6
化学式
C10H17N
mdl
——
分子量
151.252
InChiKey
YKBNOGJKTDJSLA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    15.8
  • 氢给体数:
    1
  • 氢受体数:
    0

文献信息

  • UREA INHIBITORS OF MAP KINASES
    申请人:NGUYEN Duyan
    公开号:US20100041642A1
    公开(公告)日:2010-02-18
    Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.
    本文描述了含有抑制MAP激酶的尿素类化合物、包括这些化合物的药物组合物以及使用这些化合物治疗炎症性疾病和癌症的方法。
  • [EN] INHIBITORS OF BACTERIAL GLYCOSYL TRANSFERASES<br/>[FR] INHIBITEURS DE GLYCOSYL TRANSFÉRASES BACTÉRIENNES
    申请人:HARVARD COLLEGE
    公开号:WO2016191658A1
    公开(公告)日:2016-12-01
    Described herein are compounds of Formula (I'), Formula (IA), Formulae (I)-(VII), pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrug sthereof. The invention also provides pharmaceutical compositions of the compounds for human and veterinary use. Compounds of the present invention are useful for inhibiting bacterial growth and therefore are useful in treating and/or preventing bacterial infections. Methods of using the compounds for treating and/or preventing a bacterial infection in a subject are also described.
    本文描述了式(I')、式(IA)、式(I)-(VII)的化合物,以及这些化合物的药用盐、溶剂合物、合物、多型体、共晶体、互变异构体、立体异构体、同位素标记衍生物和前药。本发明还提供了这些化合物的用于人类和兽医用途的药物组合物。本发明的化合物对抑制细菌生长有用,因此在治疗和/或预防细菌感染方面具有用途。还描述了使用这些化合物治疗和/或预防受试者细菌感染的方法。
  • COMPOUNDS AND METHODS USEFUL FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION
    申请人:Brown Matthew
    公开号:US20080312270A1
    公开(公告)日:2008-12-18
    Compounds, compositions and methods that are useful in the treatment of inflammatory and immune-related diseases and conditions are provided herein. In particular, the invention provides compounds which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer. The subject compounds are carboxylic acid derivatives.
    本文提供了在治疗炎症和免疫相关疾病和病况方面有用的化合物、组合物和方法。具体而言,本发明提供了调节参与过敏性疾病、炎症病症和癌症的蛋白质的功能和/或表达的化合物。所述化合物为羧酸生物
  • CHROMAN DERIVATIVES AS TRPM8 INHIBITORS
    申请人:AMGEN INC.
    公开号:US20150031668A1
    公开(公告)日:2015-01-29
    Chroman compounds and derivatives of Formula I are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.
    公式I的化合物和衍生物是TRPM8的有用抑制剂。这些化合物可用于治疗许多TRPM8介导的疾病和情况,并可用于制备用于治疗这些疾病和情况的药物和制剂。这些疾病的例子包括但不限于偏头痛和神经病性疼痛。公式I的化合物具有以下结构:其中变量的定义在此提供。
  • CATALYSTS CONTAINING N-PYRROLYL SUBSTITUTED NITROGEN DONORS
    申请人:EASTMAN CHEMICAL COMPANY
    公开号:EP1192189A2
    公开(公告)日:2002-04-03
查看更多